Home Patent Forecast® Sectors Log In   Contact  
How it works Patent Forecast® Sectors Pricing Insights
Enjoy your FREE PREVIEW which shows only 2021 data and 25 documents. For full access, try it free at any time.        

AI Biotech/Diagnostics: Cardio

Read More News and Insights

Boston Scientific showcases potential of its new catheter

AI Biotech/Diagnostics: Cardio Patent Forecast®

March 26, 2019

On 3/17/2019, Boston Scientific announced positive results from the AF-FICIENT I study that evaluated the safety and efficacy of its LUMINIZE™ Radiofrequency (RF) Balloon Catheter. This recently acquired single-shot ablation technology is designed to isolate the pulmonary veins (PV) when treating patients with atrial fibrillation (AF). The device identifies the areas of the heart muscle that are responsible for abnormal heart rhythms using RF energy. Meanwhile, Boston Scientific continues to innovate in the space of cardiac health, including a patent application assigned to one of its subsidiaries, Cardiac Pacemakers, that details directly measuring heart sounds using mobile device accelerometers.

Relevant Patent Documents

Application US20190083039  

Article Source Link

Boston Scientific

Read more like this in News This Week!   or   Share this link with your connections!